SCHEMBL25190699

SCHEMBL25190699

CN(C)c1ccc(Nc2ccc(/C=N/O)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.51
▸ KDM4E B2RXH2 7/20 0.51
▸ GAA P10253 2/20 0.51
▸ MPO P05164 1/20 0.51
▸ MAPT P10636 7/20 0.50
▸ KMT2A Q03164 7/20 0.50
▸ MEN1 O00255 6/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ TP53 P04637 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ MAOA P21397 1/20 0.49
▸ GRIN2D O15399 2/20 0.49
▸ GRIN3B O60391 2/20 0.49
▸ GRIN1 Q05586 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5384609 0.89 ALDH1A1 (0.62) ALDH1A1KDM4EGAAMAPTKMT2A
SCHEMBL9329089 0.89 ALDH1A1 (0.62) ALDH1A1KDM4EGAAMAPTKMT2A
SCHEMBL5384610 0.89 ALDH1A1 (0.62) ALDH1A1KDM4EGAAMAPTKMT2A
SCHEMBL22198164 0.79 ALDH1A1 (0.56) ALDH1A1KDM4EGAAMPOMAPT
SCHEMBL222247 0.78 ALDH1A1 (0.65) ALDH1A1GAAMAPTKMT2AMEN1
SCHEMBL9479616 0.78 ALDH1A1 (0.65) ALDH1A1GAAMAPTKMT2AMEN1
SCHEMBL5422583 0.77 S100B (0.59) ALDH1A1KDM4EGAAMAPTKMT2A
SCHEMBL5422579 0.77 S100B (0.59) ALDH1A1KDM4EGAAMAPTKMT2A
SCHEMBL25193110 0.76 CYP2A6 (0.76) ALDH1A1KDM4EGAAMPOMAPT
SCHEMBL25190810 0.75 ALDH1A1 (0.43) ALDH1A1KDM4EGAAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
CN-115151252-A Iron death inhibitors diarylamine para-acetamides 维泰瑞隆有限公司 2022-10-04 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 ALDH1A1 395/4885KDM4E 3495/4885GAA 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback